We are proud to present the 25th Asia-Pacific
Prostate Cancer Conference. It’s remarkable to reflect on a quarter of a
century of advances in prostate cancer care since the conference first
began.
Prostate cancer remains a significant health concern as we enter 2025, profoundly impacting the lives of countless men diagnosed daily in Australia and worldwide. Thanks to the many innovations over the past decade, men are living longer and with improved quality of life, even when diagnosed with advanced disease. But still more needs to be done.
The conference will continue to
expand on the themes of 2024, with a focus on integrating artificial
intelligence into prostate cancer diagnostic and treatment
algorithms, next generation targeted therapies and the increasing
role of metastasis directed therapies. We will explore treatment
intensification and sequencing, the role of immunotherapy in
prostate cancer and 2025 will see a return of the robotic surgery
masterclass. For our nursing and allied health attendees we will be
highlighting innovative advancements in survivorship whilst covering
critical topics including genomics, sexual rehabilitation, health
equity, and the management of patients undergoing doublet and
triplet therapies.
For the first time, the meeting will be held in Sydney, where we will engage with a wider clinical urology and nursing and allied health audience.
We look forward to seeing and engaging with
you there!